> The 2015 Nobel Prize in Physiology and Medicine was awarded to William C. Campbell and Satoshi Ömura for their discoveries leading to ivermectin. In addition to its extraordinary efficacy against parasitic diseases, ivermectin continues to offer new clinical applications[...] an increasing body of evidence points to the potential of ivermectin as an antiviral agent.
> Despite this promise, the antiviral activity of ivermectin has not been consistently proven in vivo. While ivermectin's activity against SARS-CoV-2 is currently [October 2020] under investigation in patients, insufficient emphasis has been placed on formulation challenges. Here, we discuss challenges surrounding the use of ivermectin in the context of coronavirus disease-19 (COVID-19)...
TLDR: Ivermectin turns out to have a lot of uses. Over a year ago, scientists noted that it might be useful for treating COVID-19, but anticipated that there would be problems with using it for that and suggested some possible solutions to do research on.
Kind of old right?